These EVs were taken up by macrophages and lymphocytes and decreased the cross-presentation of tumor antigens from DC cells, leading to a significant decrease in CD8 + T cell function in animal models [76] (Fig. 3a). The gene discussed is CD8A; the disease is neoplasm.